Tomáš Cihlář
Tomáš Cihlář | |
|---|---|
| Born | 1967 (age 57–58) |
| Nationality | Czech |
| Alma mater | University of Chemistry and Technology, Prague |
| Occupation(s) | Biochemist, virologist |
| Known for | Remdesivir, tenofovir disoproxil |
Tomáš Cihlář (born 1967) is a Czech biochemist known for his role in the development of remdesivir. A specialist in virology, Cihlář holds the positions of senior director, biology, and vice-president at American pharmaceutical company Gilead Sciences. As a student, Cihlář assisted fellow biochemist Antonín Holý in developing Viread, the primary drug used to fight HIV infection.